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Abstract
The demonstration of the brain’s ability to initiate repair in response to disease or injury has sparked considerable interest in
therapeutic strategies to stimulate adult neurogenesis. In this study we examined the effect of a progressive
neurodegenerative condition on neural precursor activity in the subventricular zone (SVZ) and hippocampus of the R6/1
transgenic mouse model of Huntington’s disease (HD). Our results revealed an age-related decline in SVZ precursor
numbers in both wild-type (WT) and HD mice. Interestingly, hippocampal precursor numbers declined with age in WT mice,
although we observed maintenance in hippocampal precursor number in the HD animals in response to advancement of
the disease. This maintenance was consistent with activation of a recently identified latent hippocampal precursor
population. We found that the small latent stem cell population was also maintained in the HD hippocampus at 33 weeks,
whereas it was not present in the WT. Our findings demonstrate that, despite a loss of neurogenesis in the HD hippocampus
in vivo, there is a unique maintenance of the precursor and stem cells, which may potentially be activated to ameliorate
disease symptoms.
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Introduction
It is now well established that the hippocampus and subven-
tricular zone (SVZ), even in humans, continue to undergo
neurogenesis throughout life, producing neural precursors that
differentiate into mature neurons. A number of recent studies have
also demonstrated the brain’s ability to respond to damage such as
trauma and disease through an up-regulation in neurogenesis
[1,2]. In Huntington’s disease (HD), a neurodegenerative
condition characterized by motor, psychiatric and cognitive
deficits, proliferation in neurogenic regions and the production
of neurons have also been reported [3,4]. Transgenic R6 lines of
HD mice have been well characterized and model many HD
symptoms and neuropathology, including progressive cognitive
decline, motor deficits, weight loss and neuronal dysfunction
[5–10]. It has also been demonstrated that environmental
enrichment and antidepressant treatment delay both the onset
and progression of disease in the R6/1 transgenic mouse model of
HD [6,8,11], with both experimental manipulations up-regulating
hippocampal neurogenesis and promoting maturation of migrat-
ing neurons [11,12].
In the present study, we examined the in vitro hippocampal and
SVZ precursor activity of age-matched HD and wild-type (WT)
mice, at five time points over a 33 week period, to determine what
changes occurred in response to disease progression. We found
that there was an increase in hippocampal, but not SVZ, precursor
numbers as the disease advanced. This up-regulation was
consistent with the activation of a normally latent hippocampal
precursor population [13], with no further activation being
observed in the HD hippocampus following in vitro depolarization.
Most importantly, we found that a small subset of the precursors
which have stem cell activity were maintained in the HD
hippocampus but were not found in the hippocampus of WT
littermates.
Materials and Methods
Mice and behavioral tests
Mice were derived from breeding of R6/1 hemizygous male
mice, obtained from a colony at the Howard Florey Institute
(Melbourne, Australia), with WT strain-matched B6CBAF1/J
females. The University of Queensland Animal Ethics Committee
approved all procedures (approval numbers SBMS/QBI/289/05/
UQ and QBI/453/05/BREED). Animals were examined for signs
of HD, with behavioral data being collected from cohorts of HD
and WT mice at 16, 22 and 30 weeks of age. Animals were
weighed and then examined for rear-paw clasping (RPC), an
indication of a HD phenotype in the R6/1 model, by suspending
them by their tail briefly [6,14]. Motor performance was then
assessed using an accelerating rota-rod (UGO Basile model 7650;
Sandown Scientific, Hampton, UK). Animals were scored for time
spent on the rota-rod as it accelerated from 4 rpm to 40 rpm over
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a 3 minute period. Mice were then sacrificed by cervical
dislocation and the whole brain removed and weighed.
Neurosphere assays
Primary neurospheres were generated as described previously
[15,16]. Briefly, the tissue was enzymatically digested with 0.1%
trypsin-EDTA (Gibco/Invitrogen, Eugene, OR) for 7 minutes at
37uC, followed by addition of 0.014% w/v trypsin inhibitor (type
I-S from soybean; Sigma-Aldrich, Sydney, Australia) dissolved in
Hepes-buffered minimum essential medium (HEM). The digested
tissue was centrifuged at 100 rcf for 5 minutes, after which the
pellet was resuspended in 1 ml of neurosphere growth medium,
mechanically triturated, then filtered through a 40 mm cell sieve
(Falcon/BD Biosciences, Sydney, Australia). The neurosphere
growth medium consisted of mouse NeuroCultTM NSC Basal
Medium plus mouse NeuroCultTM NSC Proliferation Supple-
ments (StemCell Technologies, Vancouver, Canada) with 0.2%
bovine serum albumin (Gibco/Invitrogen) and 2 mg/ml heparin
(Sigma-Aldrich). The following growth factors were also included:
20 ng/ml purified mouse receptor-grade epidermal growth factor
(BD Biosciences, Sydney, Australia) and 10 ng/ml recombinant
bovine basic fibroblast growth factor (Roche, Basel, Switzerland).
Cells were plated at a density of one hippocampus (approximately
2000 cells per well) or SVZ (approximately 1000 cells per well) per
96-well plate (Falcon/BD Biosciences) with 200 ml of neurosphere
growth medium per well. For the depolarization experiments,
additional KCl was added at the time of plating the primary cells
to give a final concentration of 15 mM. Previous experiments have
demonstrated the neurosphere-forming activity in the hippocam-
pus to be approximately one neurosphere for every 9227 cells
plated and in the SVZ to be one neurosphere for every 766 cells
plated [16]. Therefore, at these densities it is expected that any
neurosphere formed will be clonally derived. Primary hippocam-
pal cells were incubated for 10 days and SVZ cells for 7 days in
humidified 5% CO2. Primary neurospheres ($50 mm in diameter)
were then counted and sized using a standard light microscope
with an eyepiece graticule. Results of the neurosphere counts were
expressed as mean 6 standard error, and statistical analysis was
performed using a Students t-test (two sample assuming equal
variance).
Neurosphere differentiation and immunocytochemistry
Neurospheres were plated onto poly-D-lysine coated coverslips
in NeuroCultTM NSC basal medium containing mouse Neuro-
CultTM NSC proliferation supplements and 2% fetal calf serum
(Sigma-Aldrich) without growth factors. They were then allowed
to differentiate at 37uC for 5 days in humidified 5% CO2 until
flattened and adherent. Differentiated neurospheres were fixed
with 4% paraformaldehyde (PFA; Sigma-Aldrich) in 0.1 M
phosphate buffered saline (PBS) at room temperature for 30
minutes. After washing with PBS, neurospheres were incubated for
60 minutes at room temperature with blocking solution: 5% fetal
calf serum plus 5% normal goat serum (Sigma-Aldrich) in 0.1 M
PBS containing 0.1% Triton X-100 (Sigma-Aldrich). The blocking
solution was replaced with fresh solution containing mouse
monoclonal bIII tubulin antibody (1:2000; Promega, Madison,
WI) plus rabbit polyclonal glial fibrillary acidic protein (GFAP)
antibody (1:500; DakoCytomation, Carpinteria, CA) and incubat-
ed for 60 minutes at room temperature. Cells were washed with
PBS and incubated for 30 minutes at room temperature in
blocking solution containing Alexa Fluor 568 anti-mouse antibody
(1:1000; Molecular Probes/Invitrogen), Alexa Fluor 488 anti-
rabbit antibody (1:1000; Molecular Probes/Invitrogen) and 4,6-
diamidino-2-phenylindole (DAPI; 1:5000; Sigma-Aldrich). Follow-
ing washing with PBS, slides were coverslipped with fluorescence
mounting medium (DakoCytomation) before viewing on a Zeiss
upright fluorescence microscope. Images were captured by a
digital camera linked to a computer running Axioscope version 4
(Zeiss, Goˆttingen, Germany).
Quantification of in vivo neurogenesis
To quantify bromodeoxyuridine (BrdU)- and BrdU/GFAP-
positive cells, mice received a single intraperitoneal (i.p.) injection
of BrdU (45 mg/kg body weight), dissolved in 0.07 N NaOH in
0.9% NaCl (Sigma) 2 hours prior to perfusion. For quantification
of BrdU/doublecortin (DCX)-positive cells, mice received 6 i.p.
injections of BrdU (45 mg/kg body weight), once every 2 hours,
10 days prior to perfusion. Animals were perfused with 0.1 M PBS
followed by 4% PFA. Brains were removed and incubated
overnight in 4% PFA, followed by further overnight incubations
in 20% sucrose then 30% sucrose in 0.1 M PBS at 4uC. Frozen
sections (50 mm) were cut using a sliding microtome. Every sixth
section (approximately 7 sections per animal) was stained and
mounted. For BrdU immunohistochemistry, sections were first
denatured with 2N HCl for 30 minutes at 37uC, then washed
briefly in PBS. All sections were incubated for 60 minutes at room
temperature with blocking solution as described above. Sections
were then incubated, with rat anti-BrdU antibody (1:100; Auspep,
Melbourne, Australia), rabbit polyclonal DCX antibody (1:500;
Abcam, Cambridge, MA) or rabbit polyclonal GFAP antibody
(1:500; DakoCytomation), at 4uC overnight. Following washes
with PBS, sections were incubated for 40 minutes at room
temperature in blocking solution containing either Alexa Flour
488 donkey anti-rat secondary antibody (1:1000), or Alexa 568
anti-rabbit antibody (1:1000; Molecular Probes/Invitrogen), and
DAPI (1:1000). After washing with PBS, the slides were cover-
slipped with fluorescence mounting medium and all BrdU-, DCX-,
BrdU/GFAP- or BrdU/DCX-positive cells in the dentate gyrus of
the hippocampus were counted using a Zeiss AxioObserver with
Colibri illumination.
Results
We first examined the in vivo effects of HD progression in the
R6/1 strain by measuring four parameters: body weight, brain
weight, percentage of mice with RPC and time spent on a rota-
rod. The results showed that at 16 weeks of age HD mice were
indistinguishable from their WT littermates (Fig. 1). From 22
weeks, however, HD mice showed a significant drop in body
weight (Fig. 1A), brain weight (Fig. 1B), time spent on the rota-rod
apparatus (Fig. 1C), and 60% of the HD group displayed the RPC
phenotype (Fig. 1D). At 30 weeks of age the HD mice were even
more severely affected, and 100% of the group exhibited the RPC
motor phenotype. In contrast, there were no significant differences
observed in any of the parameters tested in WT animals across the
three ages.
We examined precursor activity across advancing age and
disease by performing in vitro neurosphere assays with tissue
harvested from the hippocampus and SVZ of HD and WT
littermates and performing in vitro neurosphere assays (Bull and
Bartlett, 2005). Results showed a drop in neurosphere number
from the SVZ of WT and HD mice over time (Fig. 2A). The
number of SVZ-derived neurospheres from WT and HD mice
decreased from 17626140 to 607684 and 13116178 to 507692,
respectively, as the mice aged from 7 to 33 weeks (Fig. 2A).
However, there was no significant difference in the total number of
SVZ-derived neurospheres between HD and WT genotypes at any
time point examined.
A Latent Stem Cell in Symptomatic HD Hippocampus
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Similar to the finding in the SVZ, there was no difference in
hippocampal neurosphere numbers between HD and WT
littermates at stages prior to the onset of motor deficits (7 or 16
weeks) (Fig. 2B). Surprisingly, as the mice aged and became
symptomatic there was a significant difference in hippocampal
precursor number in the HD mice compared to the aged-matched
WT controls (Fig. 2B). This increase in hippocampal neurosphere
activity was first observed at 22 weeks, with HD mice showing an
approximately 2-fold increase in neurosphere numbers compared
to their WT littermates. With disease progression the up-
regulation of in vitro precursor activity increased still further, with
mice aged 30 and 33 weeks recording a significant 3.5- and 4-fold
increase in neurosphere number respectively, compared to their
WT littermates (Fig. 2B).
Recently, we demonstrated that the adult hippocampus contains
a large number of latent precursors, including a self-renewing stem
cell population, which only becomes activated following depolar-
ization [13]. We therefore next explored whether it was this
precursor cell population that was being activated in the HD mice.
At 7 and 16 weeks, prior to the emergence of symptoms, both WT
and HD mice had a similar number of neurosphere-forming cells
(Fig. 2C). In addition, in vitro depolarization increased the number
of hippocampal neurospheres generated from both genotypes
approximately 3-fold (Fig. 2C). In contrast, at 33 weeks there was a
significant increase in the number of neurospheres generated,
under low K+ culture conditions, from the hippocampus of HD
mice compared to WT littermate controls (Fig. 2C). Consistent
with our previous findings in an in vivo seizure model [13], the
precursor population in the 33-week old HD hippocampus was
also completely activated, as no significant further increase in
neurosphere number occurred following KCl depolarization in
vitro (Fig. 2C). In addition, the number of neurospheres cultured in
control conditions (low K+) from the 33-week old HD mice was
similar to that obtained in depolarizing conditions (high K+) from
WT littermates, further indicating complete activation of the
precursor population in the HD hippocampus (Fig. 2C).
It is known that neurosphere size is directly related to
proliferative capacity and we have previously shown that only
very large hippocampal neurospheres, with diameters over
250 mm, are derived from stem cells [13]. At pre-symptomatic
time-points, in addition to activating a progenitor cell population,
KCl depolarization was also able to activate the previously
characterized latent stem cell population, as evidenced by the
formation of a number of large (.250 mm diameter) neurospheres
from both WT and HD hippocampi (Fig. 3A). We have previously
reported that in the hippocampus of older WT mice we were no
longer able to activate this stem cell population but rather could
activate only a more restricted progenitor population [13]. In
accordance with this observation, no large stem cell-derived
neurospheres could be generated from 33-week old WT mice in
the present study. Surprisingly, large neurospheres were generated
in the 33-week old HD cultures following depolarization in vitro
(Fig. 3A), indicating that the latent stem cell population was
retained in the HD hippocampus and could be activated. As
expected, when the large stem cell-derived neurospheres generated
from pre-symptomatic 7- and 16-week old HD and WT mice were
differentiated and stained they gave rise to GFAP-positive
astrocytes as well as a small number of bIII-tubulin-positive
neurons. Although the smaller progenitor-derived neurospheres
generated from the 33-week old WT animals only produced
Figure 1. Correlation between behavioral deficits in HD and WT mice and disease progression. (A) Body weights of HD mice are
significantly lower than those of their WT littermates at 22 and 30 weeks. (B) HD mice had lower whole brain weights at 22 and 30 weeks than their
WT littermates. (C) At 22 and 30 weeks HD mice have poorer motor ability and fall off the accelerating rota-rod at lower speeds than WT littermates.
(D) The percentage of HD mice expressing the rear-paw clasping (RPC) motor phenotype increases to 100% by 30 weeks. Data are expressed as mean
6 s.e.m, n$3 animals, *p#0.05.
doi:10.1371/journal.pone.0018153.g001
A Latent Stem Cell in Symptomatic HD Hippocampus
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astrocytes (Fig. 3B, D), the large neurospheres generated from the
33-week old HD hippocampus gave rise to a small number of
neurons (Fig. 3C, E).
Figure 2. Increased precursor activity in the hippocampus but
not the SVZ of symptomatic HD mice. (A) Similar numbers of SVZ-
derived neurospheres were generated from HD and WT littermates at
all time points examined. (B) A significant increase in the number of
hippocampal-derived neurospheres in HD mice compared to WT
littermates was observed at 30 (n=5) and 33 weeks of age (n=4). (C)
Younger (16-week old) HD mice generated a similar number of
hippocampal neurospheres to their WT littermates and the number of
neurospheres could be increased by the addition of depolarizing levels
of KCl (n = 3). More neurospheres were generated from older
symptomatic HD mice (33 weeks; n= 4) than the corresponding WT
mice. However, unlike the WT mice, which show a significant increase in
neurosphere number following in vitro depolarization, no further
increase was observed in the HD mice in the presence of additional
KCl. All data are expressed as mean 6 s.e.m, *p#0.05, **p#0.01,
***p#0.001.
doi:10.1371/journal.pone.0018153.g002
Figure 3. Large stem cell-derived neurospheres were generat-
ed from 33-week old HD hippocampus, but not WT hippocam-
pus. (A) Similar numbers of large ($250 mm in diameter) hippocampal
neurospheres were generated from HD (n= 4) and WT (n= 4) mice at 5
weeks of age. However, by 33 weeks, large neurospheres could only be
generated from the HD hippocampus (n=4) and not the WT (n= 5)
hippocampus. Data are expressed as mean 6 s.e.m. Representative
images of a small progenitor-derived neurosphere from a 33-week old
WT hippocampus (B) and a large stem cell-derived neurosphere from a
33-week old HD hippocampus (C). Small neurospheres generated from
the 33-week old WT hippocampus gave rise exclusively to astrocytes
(shown in green; D), whereas the large neurospheres generated from
the 33-week old HD hippocampus gave rise to astrocytes (green) and a
small number of neurons (red; E). Scale bars in B and C are 100 mm.
doi:10.1371/journal.pone.0018153.g003
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Finally, we examined whether the increase in precursor activity
that we observed in the 33-week old HD mice using the in vitro
neurosphere assay resulted in an increase in hippocampal
neurogenesis in vivo. To address this we stained hippocampal
sections taken from 33-week old HD and WT animals, which had
received BrdU injections, with markers for proliferating cells
(BrdU), newly born neurons (DCX), and astrocytes/stem cells
(GFAP). Interestingly, we found a significant decrease in BrdU-,
DCX-, BrdU/DCX- and BrdU/GFAP-positive cells in the
symptomatic HD hippocampus compared to the WT hippocampus
(Fig. 4, Fig. 5).
Discussion
Here we have shown that as HD mice became symptomatic
there is a significant increase in in vitro hippocampal precursor
activity compared to that of aged-matched WT controls. Most
importantly, we have also found that although a latent stem cell
population is no longer present in the WT hippocampus after 30
weeks of age, it is maintained in the HD hippocampus. In contrast,
precursor numbers in the SVZ decrease with age, although no
effect of HD disease progression was observed.
Our observation that HD progression had no effect on SVZ
precursor numbers was in contrast to a recent report by Batista
and colleagues [17], who showed a progressive increase in SVZ
activation in R6/2 HD mice with disease progression. The lack of
SVZ activation in our study could be due to the fact that the
Batista study was examining R6/2 animals [5], which represent a
more severe model, bearing a closer resemblance to juvenile-onset
HD. Another study by Curtis et al. [3] also reported an increase in
SVZ neurogenesis; however, these authors examined post-mortem
tissue from patients who had been symptomatic for many years,
such that a large number of striatal neurons would have already
died. Therefore, the observed increase may have been due to a late
and failed response to massive cell death. At the time-points used
in the present study there would be very little or no cell death in
the R6/1 striatum or other areas, explaining why we see no
increase in the number of SVZ precursors. This suggests that the
progenitors are reactive to their environment and are capable of
initiating varying degrees of activation depending on the level of
damage.
We have recently demonstrated that depolarization resulted in
the activation of a latent precursor population in the adult mouse
hippocampus [13], and that depolarizing levels of KCl led to the
activation of a small subpopulation of stem cells with the capacity
to generate very large neurospheres [13]. More importantly, we
have also shown that this latent hippocampal progenitor
population can be activated in vivo in response to prolonged
neural activity, such as that found in status epilepticus. Although
hippocampal neurogenesis has been shown to decrease with age
[18,19], we have demonstrated here that in the oldest symptomatic
HD animals tested (33 weeks) there was in fact a significant
increase in precursor numbers in vitro to levels greater than those
recorded in much younger WT animals (16 weeks). While the
latent stem cell population (as evidenced by the formation of
neurospheres.250 mm in diameter) was lost in the WT animals at
33-weeks of age, it was maintained in HD animals of the same age.
It has previously been shown that symptomatic HD mice are
prone to epileptic seizures, and there is also evidence that the
increased electrical activity that occurs during seizures can lead to
increases in neurogenesis in the dentate gyrus. This could
potentially be one mechanism for the increased precursor activity
we observe in the hippocampus following HD disease progression.
It is important to note, however, that similar to the results we
previously observed following status epilepticus, although we could
culture more neurospheres from the symptomatic HD hippocam-
pus we were unable to culture any of the large neurospheres prior
to depolarization in vitro. However, following depolarization,
Figure 4. Quantification of in vivo neurogenesis in the hippocampus of symptomatic HD and WT mice. Significantly fewer BrdU-positive
(A, n=8 HD and n= 9 WT animals), DCX-positive (B, n= 5 HD and n=6 WT animals), BrdU/DCX double-positive (C, n= 5 HD and n=6 WT animals) and
BrdU/GFAP double-positive (D, n=8 HD and n= 9 WT animals) cells were observed in the hippocampus of 33-week old HD mice compared to WT
littermates. Data are expressed as mean 6 s.e.m, *p#0.05, **p#0.01.
doi:10.1371/journal.pone.0018153.g004
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activation of the latent stem cell occurred, as evidenced by the
generation of a number of large neurospheres in the 33-week old
HD but not the WT hippocampus.
Previously, it has been shown in the 20-week HD hippocampus,
that there was a volume loss in the dentate gyrus as well as a
significant decrease in both the number and percentage of NeuN/
BrdU double-positive cells, however there was no significant
decrease in the number of hippocampal-derived neurospheres
[11]. In agreement with this, we also observed no significant
difference in the number of neurospheres generated from the
hippocampus of either 16- or 22-week-old HD and WT mice.
Interestingly, at the much later time point of 33 weeks, although
we observed a significant increase in the number of neurospheres
generated from the HD hippocampus, we saw a significant
decrease in BrdU-positive, DCX-positive and BrdU/DCX
double-positive cells. Surprisingly, in a previous study, Lazic and
colleagues observed maintenance of BrdU-positive cells at 25
weeks [12,20], which differed from our findings at 33 weeks. If
correct, this could indicate some activation of the precursors in
HD animals around this stage, which would account for the
increase in neurospheres we observed in the 30- and 33-week-old
HD hippocampus.
One possible explanation for the increase in neurosphere
numbers observed in the 33-week-old HD hippocampus is that the
degenerating hippocampal environment present during HD
progression may in fact lead to the release of factors in vivo which
may help to maintain the stem/progenitor cell pool at its normal
adult level, but not allow these cells to actively proliferate. This
would explain why we observed no increase in neurogenesis in the
HD hippocampus in vivo. If cells are primed by the degenerating
environment present in HD progression but do not have the
appropriate signals to proliferate there will be no increase in
neurogenesis. It may be that once these primed precursor cells are
cultured in vitro in the presence of the appropriate growth factors
that they can then proliferate to form neurospheres. This could
explain why in the symptomatic HD brain, although there was loss
of neurogenesis in vivo, there was maintenance of the precursor
cells capable of being activated.
Although it is not known how many types of latent stem cell
populations are present in the adult hippocampus to date we have
shown two. One, which is activated directly by nor-epinephrine
[21] and one, which is activated, indirectly, by high potassium
through the release of other soluble factors [13]. Both of these are
dependent on FGF-2 for their proliferation and show extensive
capacity for self-renewal. Although there remains the possibility
that there are other latent populations that are regulated by other
cytokines these cells will not be activated under the neurosphere
growth conditions used in these experiments. The question of
whether the stem cells we have identified are totally restricted to
the neural lineage is difficult to answer unequivocally since it may
Figure 5. Representative images from the immunstaining of 33-week-old WT and HD hippocampus. Representative images of BrdU (A)
and DCX (B) staining in the WT hippocampus. Composite images of BrdU (red) and DCX (green) double-staining in the WT (C) and HD (D)
hippocampus. Composite images of BrdU (red) and GFAP (green) double-staining in the WT (E) and HD (F) hippocampus. All images were taken using
the 20x objective.
doi:10.1371/journal.pone.0018153.g005
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depend on providing the appropriate milieu, suffice to say only
cells of a neural lineage are produced under the differentiation
conditions used in this study.
In addition, the capacity of neural progenitor cells to
differentiate into region-specific neurons is a very important issue.
Only those neural stem cells that can differentiate into region-
specific neurons to replace damaged neuron types have a valuable
application in regenerative medicine. We have preliminary data
showing that ablation of the latent stem cell population in the adult
hippocampus (genetic ablation of Nestin-positive stem cells), results
in a significant decrease (approximately 30%) in doublecortin-
positive neurons in the hippocampus four weeks post ablation
(Walker et al., unpublished data). Therefore, importantly,
indicating that the latent stem cell population is capable of giving
rise to region-specific hippocampal neurons.
In conclusion, this study has revealed that the hippocampus
contains a population of progenitors capable of responding to a
changing environment. The up-regulation of in vitro hippocampal
progenitor activity observed in response to an advancing disease
state demonstrates a potential source of cells that could be
manipulated to replace degenerating neurons. This inability of
precursors to be activated to produce neurons may be one of the
fundamental mechanisms underpinning the loss of neurogenesis in
HD. Further experiments will be able to determine exactly what
blocks the production of neurons from the latent precursors in
HD. This may not only allow the restoration of neurogenesis, but
may also allow this process to be harnessed to repair other areas of
neuronal cell loss.
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